Uncategorized

Pharma stocks survive market rout on tariff exemption, but uncertainty continues – Reuters

Posted on Author Tim Hodges Comments Off on Pharma stocks survive market rout on tariff exemption, but uncertainty continues – Reuters
  1. Pharma stocks survive market rout on tariff exemption, but uncertainty continues  Reuters
  2. Pharma Stocks Aren’t in the Clear, Despite Tariff Exemption—Heard on the Street  WSJ
  3. Prescription drugs dodge Trump’s worldwide tariff for now. What to know.  USA Today
  4. India’s generic medicines steal the spotlight as US exempts pharma from tariffs  Times of India
  5. Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert to the Dangers Ahead.  Barron’s